Physician profile
Jordan Smith
NPI 1871025536
$1,757.75
in general payments reported to CMS, 2019-2025
11 companies · $265 in 2025
The $265 reported for 2025 was more than what 85% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $110 · 2021: $95.94 · 2022: $449 · 2023: $761 · 2024: $77.36 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $765 · Travel and Lodging: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $764.57 |
| Travel and Lodging | $338.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $358.70 | 2022-2023 | Xeomin |
| Sage Therapeutics, LLC | $350.00 | 2022 | |
| Stryker Corporation | $338.26 | 2023 | 1688 |
| Revance Therapeutics, INC. | $196.06 | 2025 | Daxxify |
| Allergan, INC. | $175.85 | 2020-2021 | |
| Coloplast Corp | $175.78 | 2023-2024 | Titan |
| Cumberland Pharmaceuticals, INC. | $44.50 | 2024-2025 | Caldolor |
| Merck Sharp & Dohme LLC | $33.61 | 2024-2025 | Bridion |
| Baxter Healthcare | $30.37 | 2021 | |
| Boston Scientific Corporation | $28.29 | 2025 | Enroute Transcarotid Neuroprotection System |
| Abbvie INC. | $26.33 | 2023 | Avycaz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.